Table 2.

Follow-up schedule

	Eligibility test	0 week	12 weeks	24 weeks
Patient information/obtaining consent	a
Patient background	a
Interview/physical examination	a	a	a	a
Confirmation of drug compliance			a	a
Confirmation of study procedure compliance		a	a	a
Confirmation of concomitant drug use	a	a	a	a
Height	a
Body weight/body temperature	a	a	b	a
Blood pressure/pulse rate		a	b	a
Blood tests	a	a	b	a
Blood tests (specific)		a	b	a
12-lead ECG		a		a
Holter monitoring		a		a
Echocardiography	a	a		a
123I-MIBG myocardial scintigraphy		b		b
Safety assessment	a	a	a	a
Evaluation of ICD		a		a

^aPrimary or secondary outcome measure

^bOptional